56 | Peptides (Polypeptides)IBA
05/2023
-
02/2002 |
36 | alpha-MSHIBA
05/2023
-
02/2002 |
27 | Type 1 Melanocortin ReceptorIBA
02/2022
-
11/2003 |
21 | LactamsIBA
05/2023
-
02/2008 |
17 | AcidsIBA
05/2023
-
08/2005 |
15 | Melanocyte-Stimulating Hormones (MSH)IBA
01/2023
-
08/2009 |
14 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
02/2022
-
02/2002 |
11 | Radioisotopes (Radionuclides)IBA
01/2021
-
02/2002 |
8 | RadiopharmaceuticalsIBA
04/2024
-
07/2002 |
8 | triazacyclononaneIBA
05/2023
-
06/2012 |
7 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
05/2023
-
06/2012 |
7 | arginylprolineIBA
11/2014
-
04/2009 |
6 | Amino AcidsFDA Link
12/2014
-
10/2002 |
5 | IntegrinsIBA
01/2021
-
11/2010 |
5 | N-glycylglutamic acidIBA
06/2012
-
02/2008 |
4 | Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
05/2023
-
12/2014 |
4 | Chelating AgentsIBA
12/2020
-
05/2009 |
4 | MetalsIBA
01/2020
-
02/2002 |
4 | Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2017
-
08/2011 |
4 | arginyl-glycyl-aspartic acidIBA
04/2015
-
08/2009 |
3 | cysteinylcysteineIBA
11/2014
-
09/2013 |
3 | lysinenorleucineIBA
06/2012
-
04/2009 |
3 | RheniumIBA
11/2007
-
02/2002 |
2 | omega-aminocaprylic acidIBA
01/2023
-
12/2014 |
2 | phenylalanylarginineIBA
01/2023
-
12/2020 |
2 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
12/2020
-
01/2020 |
2 | BombesinIBA
07/2018
-
02/2015 |
2 | tryptophylglycineIBA
06/2012
-
11/2009 |
2 | Ac- Cys- Cys- Glu- His- D- Phe- Arg- Trp- Cys- Lys- Pro- Val- NH2IBA
11/2010
-
08/2006 |
2 | Lysine (L-Lysine)FDA Link
11/2007
-
10/2002 |
2 | Therapeutic UsesIBA
06/2007
-
01/2005 |
2 | 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA
01/2007
-
04/2005 |
1 | AlbuminsIBA
02/2022 |
1 | Ethylene Glycol (Monoethylene Glycol)IBA
01/2022 |
1 | Integrin alpha4beta1 (VLA-4)IBA
01/2021 |
1 | Bombesin Receptors (Bombesin Receptor)IBA
02/2015 |
1 | LigandsIBA
02/2015 |
1 | HydrocarbonsIBA
12/2014 |
1 | EDDA (NiEDDA)IBA
12/2014 |
1 | MelanocortinsIBA
11/2014 |
1 | aspartyllysineIBA
11/2013 |
1 | alanylaspartic acidIBA
02/2012 |
1 | LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
08/2011 |
1 | N- (2- aminoethyl)- 1,2- diaminocyclohexane- N,N',N''- pentaacetic acid-Re(Cys(3,4,10))-Phe(7)-Arg(11)- alpha-MSH(3-13)IBA
05/2009 |
1 | N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA
05/2009 |
1 | Deoxyglucose (2 Deoxy D glucose)IBA
04/2009 |
1 | ACTH (7-10)IBA
04/2009 |
1 | Melanins (Melanin)IBA
09/2008 |
1 | PlacebosIBA
06/2007 |
1 | AntigensIBA
03/2007 |
1 | Biomarkers (Surrogate Marker)IBA
03/2007 |
1 | Peptide LibraryIBA
03/2007 |
1 | StreptavidinIBA
03/2007 |
1 | Glutamic Acid (Glutamate)FDA Link
08/2006 |
1 | Oxygen (Dioxygen)IBA
08/2005 |
1 | OF 900IBA
11/2003 |
1 | Indium-111IBA
02/2002 |